Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Yi Li1,2, Xiaomin Xiong1,2, Xiaohua Liu3
1School of Medicine, Chongqing University, Chongqing, China.
This study developed a multimodal model (MIAM-C) to predict BRCA1/2 gene status and patient prognosis for PARPi cancer treatment. The MIAM-C model accurately identified BRCA1/2 mutations and improved risk stratification for better treatment decisions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: